Express News | HC Wainwright & Co. Reiterates Buy on Apellis Pharmaceuticals, Maintains $92 Price Target

Moomoo 24/7Apr 15 07:07 ET

Analysts Offer Insights on Healthcare Companies: Aslan Pharmaceuticals (ASLN), Rewalk Robotics (LFWD) and Apellis Pharmaceuticals (APLS)

TipRanksApr 15 06:20 ET

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,000 Today

Apellis Pharmaceuticals (NASDAQ:APLS) has outperformed the market over the past 5 years by 11.97% on an annualized basis producing an average annual return of 24.08%. Currently, Apellis Pharmaceutical

BenzingaApr 10 15:00 ET

Apellis Pharmaceuticals(APLS.US) Officer Sells US$3.74 Million in Common Stock

$Apellis Pharmaceuticals(APLS.US)$ Officer Deschatelets Pascal sold 69,107 shares of common stock on Apr 8, 2024 at an average price of $54.1711 for a total value of $3.74 million.Source: Announcement

moomoo NewsApr 9 17:08 ET

Apellis Pharmaceuticals Insider Sold Shares Worth $3,743,605, According to a Recent SEC Filing

Pascal Deschatelets, Chief Scientific Officer, on April 08, 2024, sold 69,107 shares in Apellis Pharmaceuticals (APLS) for $3,743,605. Following the Form 4 filing with the SEC, Deschatelets has contro

MT NewswiresApr 9 16:33 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE), Apellis Pharmaceuticals (APLS) and ACADIA Pharmaceuticals (ACAD)

TipRanksApr 9 06:40 ET